+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Esophageal Cancer Market and Competitive Landscape - 2020

  • ID: 5023428
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Esophageal Cancer Market and Competitive Landscape - 2020, provides comprehensive insights into the Esophageal Cancer pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Esophageal Cancer market size and drug sales. It also provides insights into Esophageal Cancer epidemiology and late stage pipeline.

This research covers the following: Esophageal Cancer treatment options, Esophageal Cancer late stage clinical trials pipeline, Esophageal Cancer prevalence by countries, Esophageal Cancer market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Esophageal Cancer pipeline: Find out drugs in clinical trials for the treatment of Esophageal Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Esophageal Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Esophageal Cancer by countries
  • Esophageal Cancer drugs: Identify key drugs marketed and prescribed for Esophageal Cancer in the US, including trade name, molecule name, and company
  • Esophageal Cancer drugs sales: Find out the sales value for Esophageal Cancer drugs by countries
  • Esophageal Cancer market valuations: Find out the market size for Esophageal Cancer drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Esophageal Cancer drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Esophageal Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Esophageal Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze Esophageal Cancer drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Esophageal Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Esophageal Cancer Treatment Options

2. Esophageal Cancer Pipeline Insights
2.1. Esophageal Cancer Phase 3 Clinical Trials
2.2. Esophageal Cancer Phase 2 Clinical Trials
2.3. Esophageal Cancer Phase 1 Clinical Trials

3. Esophageal Cancer Epidemiology Analysis by Countries

4. Germany Esophageal Cancer Market Insights
4.1. Marketed Drugs for Esophageal Cancer in Germany
4.2. Germany Esophageal Cancer Market Size & Forecast
4.3. Germany Esophageal Cancer Drugs Sales Forecast
4.4. Germany Esophageal Cancer Market Share Analysis

5. France Esophageal Cancer Market Insights
5.1. Marketed Drugs for Esophageal Cancer in France
5.2. France Esophageal Cancer Market Size & Forecast
5.3. France Esophageal Cancer Product Sales Forecast
5.4. France Esophageal Cancer Market Share Analysis

6. Italy Esophageal Cancer Market Insights
6.1. Marketed Drugs for Esophageal Cancer in Italy
6.2. Italy Esophageal Cancer Market Size & Forecast
6.3. Italy Esophageal Cancer Product Sales Forecast
6.4. Italy Esophageal Cancer Market Share Analysis

7. Spain Esophageal Cancer Market Insights
7.1. Marketed Drugs for Esophageal Cancer in Spain
7.2. Spain Esophageal Cancer Market Size & Forecast
7.3. Spain Esophageal Cancer Product Sales Forecast
7.4. Spain Esophageal Cancer Market Share Analysis

8. UK Esophageal Cancer Market Insights
8.1. Marketed Drugs for Esophageal Cancer in UK
8.2. UK Esophageal Cancer Market Size & Forecast
8.3. UK Esophageal Cancer Product Sales Forecast
8.4. UK Esophageal Cancer Market Share Analysis

9. Europe Esophageal Cancer Market Insights
9.1. Europe Esophageal Cancer Market Size & Forecast
9.2. Europe Esophageal Cancer Product Sales Forecast
9.3. Europe Esophageal Cancer Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Esophageal Cancer Phase 3 Clinical Trials, Global, 2020
Table 2: Esophageal Cancer Phase 2 Clinical Trials, Global, 2020
Table 3: Esophageal Cancer Phase 1 Clinical Trials, Global, 2020
Table 4: Esophageal Cancer Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Esophageal Cancer in Germany, 2019
Table 6: Germany Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Esophageal Cancer Product Sales ($mn), 2016 - 2024
Table 8: Germany Esophageal Cancer Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Esophageal Cancer in France, 2019
Table 10: France Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Esophageal Cancer Product Sales ($mn), 2016 - 2024
Table 12: France Esophageal Cancer Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Esophageal Cancer in Italy, 2019
Table 14: Italy Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Esophageal Cancer Product Sales ($mn), 2016 - 2024
Table 16: Italy Esophageal Cancer Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Esophageal Cancer in Spain, 2019
Table 18: Spain Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Esophageal Cancer Product Sales ($mn), 2016 - 2024
Table 20: Spain Esophageal Cancer Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Esophageal Cancer in UK, 2019
Table 22: UK Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Esophageal Cancer Product Sales ($mn), 2016 - 2024
Table 24: UK Esophageal Cancer Market Events and Trends, 2016 - 2024
Table 25: Europe Esophageal Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Esophageal Cancer Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Esophageal Cancer Pipeline by Phase (%), Global, 2020
Figure 2: Esophageal Cancer Prevalence by Countries, 2016 - 2024
Figure 3: Germany Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 4: Germany Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 5: Germany Esophageal Cancer Market Share by Drugs (%), 2019
Figure 6: Germany Esophageal Cancer Market - Future Market Share (%), 2024
Figure 7: France Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 8: France Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 9: France Esophageal Cancer Market Share by Drugs (%), 2019
Figure 10: France Esophageal Cancer Market - Future Market Share (%), 2024
Figure 11: Italy Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 12: Italy Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 13: Italy Esophageal Cancer Market Share by Drugs (%), 2019
Figure 14: Italy Esophageal Cancer Market - Future Market Share (%), 2024
Figure 15: Spain Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 16: Spain Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 17: Spain Esophageal Cancer Market Share by Drugs (%), 2019
Figure 18: Spain Esophageal Cancer Market - Future Market Share (%), 2024
Figure 19: UK Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 20: UK Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 21: UK Esophageal Cancer Market Share by Drugs (%), 2019
Figure 22: UK Esophageal Cancer Market - Future Market Share (%), 2024
Figure 23: Europe Esophageal Cancer Market Size ($mn), 2016 - 2024
Figure 24: Europe Esophageal Cancer Product Sales ($mn), 2016 - 2024
Figure 25: Europe Esophageal Cancer Market Share by Drugs (%), 2019
Figure 26: Europe Esophageal Cancer Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll